Ivermectin is certainly controversial. There is clearly some hope that it can be valid "cure" (Chaccour et al., 2020). But it clearly comes with some risk, as - according to my understanding - it can complicate things in the central nervous system should it pass the blood brain barrier (BBB). While this may seem unlikely, it can be problematic in sick people. And at a macro level, there are certainly some encouraging statistics, such as in your article. However, in controlled randomized trials, ivermectin did not perform well on patients with mild COVID 19 (López-Medina et al., 2021).Indian Bar Association sues WHO scientist over Ivermectin
The Indian Bar Association (IBA) sued WHO Chief Scientist Dr. Soumya Swaminathan on May 25, accusing her in a 71-point brief of causing the deaths of Indian citizens by misleadingwww.thedesertreview.com
I hope it turns out to be the cure all, but I certainly understand due diligence.
links to the two studies cited:
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
www.ncbi.nlm.nih.gov
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
This randomized trial compares the effects of ivermectin vs placebo on time to symptom resolution within 21 days among patients with mild COVID-19.
jamanetwork.com